Company: NDRA
Filing Date: 2025-11-26
Form Type: 424B4
Source: 0001213900-25-115097
Chunk: 2

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-11-26
Form: 424B4
Chunk 2
---
 reference into this prospectus or any applicable free writing prospectus. You must not rely upon any information or representation not contained in or incorporated by reference into this prospectus or any applicable free writing prospectus as if we had authorized it. This prospectus and any applicable free writing prospectus do not constitute an offer to sell or the solicitation of an offer to buy any securities other than the registered securities to which they relate, nor does this prospectus or any applicable free writing prospectus constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction. You should not assume that the information contained in this prospectus, the documents incorporated herein and therein by reference and any applicable free writing prospectus is correct on any date after their respective dates, even though this prospectus or an applicable free writing prospectus is delivered or securities are sold on a later date. Our business, financial condition, results of operations and cash flows may have changed since those dates.

<div align='center'>i

ABOUT THIS PROSPECTUS</div>

This prospectus is part of
a registration statement on Form S-3 that we filed with the Securities and Exchange Commission, or SEC, utilizing a shelf registration
process, pursuant to which the selling stockholders named herein may, from time to time, offer and sell or otherwise dispose of the securities
covered by this prospectus. This prospectus describes the specific terms of this offering. We urge you to carefully read this prospectus
and the documents incorporated by reference herein and therein, before buying any of the securities being offered under this prospectus.
To the extent that any statement that we make in this prospectus is inconsistent with statements made in any documents incorporated by
reference herein filed prior to the date of this prospectus, the statements made in this prospectus will be deemed to modify or supersede
those made in such documents incorporated by reference herein.

You should rely only on the
information contained in this prospectus and any related free-writing prospectus that we or the selling stockholders provide to you or
incorporated herein by reference in this prospectus. Neither we nor the selling stockholders have authorized anyone to provide you with
different or additional information. If anyone provides you with different, additional or inconsistent information, you should not rely
on it.

The selling stockholders
are offering to sell securities only in jurisdictions where such offers and sales are permitted. The distribution of this prospect